Back
Product details:
CAS
915942-22-2
Purity
95%
Neratinib is a tyrosine kinase inhibitor which exhibits antitumor action against Epidermal Growth Factor Receptor, HER2, and Human Epidermal Growth Factor Receptor 4 (HER4) postive carcinomas. It is used to treat breast cancer that over expresses the HER2 receptor.
Properties
Name
Neratinib maleate
Smiles
CCOC=1C=C2N=CC(C#N)=C(NC=3C=CC(OCC=4C=CC=CN4)=C(Cl)C3)C2=CC1NC(=O)/C=C/CN(C)C.OC(=O)/C=C\C(=O)O
Targets
Please log in to see this information
SDS
HKI-272 | neratinib | neratinib maleate | nerlynx
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$108
2 mg
$162
5 mg
$324
10 mg
$561
15 mg
$680
20 mg
$799
25 mg
$972
30 mg
$1144
35 mg
$1317
40 mg
$1490
45 mg
$1598
50 mg
$1706
75 mg
$2268
100 mg
$POA
Quantity
1
Total amount
$ 324
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.